tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Avidity Biosciences Inc (RNA)
NASDAQ:RNA
US Market
RNA
Avidity Biosciences
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Avidity Biosciences (RNA) Stock News & Sentiment

Compare
764 Followers
Avidity Biosciences’ Promising Progress in FORTITUDE Study Boosts Buy Rating
Premium
Ratings
Avidity Biosciences’ Promising Progress in FORTITUDE Study Boosts Buy Rating
11d ago
RNA
Avidity Biosciences Positioned for Market Leadership with Strategic Advancements in Dystrophy Programs
Premium
Ratings
Avidity Biosciences Positioned for Market Leadership with Strategic Advancements in Dystrophy Programs
12d ago
RNA
Avidity Biosciences’ Promising Developments in DMD Treatment and Strategic Preparations for Future Success
Premium
Ratings
Avidity Biosciences’ Promising Developments in DMD Treatment and Strategic Preparations for Future Success
25d ago
RNA
Buy Rating for Avidity Biosciences Driven by Strategic Leadership and Patient-Centric Approach
Premium
Ratings
Buy Rating for Avidity Biosciences Driven by Strategic Leadership and Patient-Centric Approach
25d ago
RNA
Avidity Biosciences: Strategic Advancements in DMD Program and Promising Market Potential Justify Buy Rating
Premium
Ratings
Avidity Biosciences: Strategic Advancements in DMD Program and Promising Market Potential Justify Buy Rating
26d ago
RNA
Optimistic Buy Rating for Avidity Biosciences Driven by Promising DMD Treatment and Strategic Expansion Plans
Premium
Ratings
Optimistic Buy Rating for Avidity Biosciences Driven by Promising DMD Treatment and Strategic Expansion Plans
26d ago
RNA
Promising Trial Results and Strong Growth Potential Lead to Buy Rating for Avidity Biosciences
Premium
Ratings
Promising Trial Results and Strong Growth Potential Lead to Buy Rating for Avidity Biosciences
27d ago
RNA
More RNA News >

RNA News on the Web

Avidity Gets Orphan Drug Status In Japan For Delpacibart Etedesiran In Myotonic Dystrophy Type 1
rttnews
Neutral
Avidity Biosciences (RNA) Soars 11.3%: Is Further Upside Left in the Stock?
Zacks
Neutral
Marks resignation 'not good' for biotech sector, says RBC
The Fly
Neutral
Avidity Biosciences Inc (RNA) Announces Inducement Grants for New Employees
GuruFocus News
Bullish
Avidity Biosciences (RNA) Gets a Buy from TD Cowen
TipRanks News
Neutral
Avidity Biosciences (RNA) Gets a Buy from Wells Fargo
TipRanks News
Neutral
Avidity Biosciences Full Year 2024 Earnings: Revenues Beat Expectations, EPS In Line
Yahoo Finance
Neutral
Avidity Biosciences, Inc. (RNA) Reports Q4 Loss, Tops Revenue Estimates
Zacks
Neutral

News Score - Last 7 Days

Neutral
RNA
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average61%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RNA’s Media Buzz Sentiment?
1 articles about RNA were published this week. In an average week, 1 articles are published.
    What is RNA’s weekly average amount of articles?
    In an average week, 1 articles about RNA are published.
      What is RNA’s News Sentiment?
      50% of articles about RNA were positive this week, compared to its sector average of 61%.
        Healthcare Stocks that are Trending in the News
        THTXTheratechnologies
        RYTMRhythm Pharmaceuticals
        NKTRNektar Therapeutics
        SENSSenseonics Holdings
        MBOTMicrobot Medical
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing